Our Capecitabine Tablets are present in the market as orally administered chemotherapeutic agent. The proposed range is widely required for treating metastatic breast and colorectal cancers. Basically, Capecitabine is present as prodrug, which is enzymatically converted antimetabolite called fluororacil in most of the tumor. The tablets act by inhibiting the synthesis of DNA while slowing down the growth of tumor tissue. Moreover, it can be used alone or as an adjuvant therapy while completely restricting the synthesis of tumor cell. Clients can obtain these Capecitabine Tablets from us at most economical rates.
Developed and Managed by Infocom Network Private Limited.